Expression and quantification of LYVE-1 in human colorectal cancer

被引：33

作者：

Gao, F. ^{[1
]}

Lu, Y. M. ^{[1
]}

Cao, M. L. ^{[1
]}

Liu, Y. W. ^{[1
]}

He, Y. Q. ^{[1
]}

Wang, Y. ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Sch Med, Dept Lab Med, Peoples Hosp 6, Shanghai 200233, Peoples R China

来源：

CLINICAL AND EXPERIMENTAL MEDICINE | 2006年 / 6卷 / 02期

关键词：

LYVE-1; colorectal cancer; lymphangiogenesis;

D O I：

10.1007/s10238-006-0097-4

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The recent discovery of a new hyaluronan (HA) receptor, LYVE-1 (lymphatic vessel endothelial HA receptor), has been received with great interest regarding its specific expression in the lymphatic system. The process of lymphangiogenesis or the formation of new lymphatics in tumours is important because it serves as a major route for cancer metastasis. Therefore, methods to quantify lymphangiogenesis by measuring LYVE-1 have been studied extensively in searching for its possible role in cancer diagnosis, prognosis and even targeted treatment of lymphatic tumour metastasis. Here we report a quantitation study on lymphangiogenesis by either quantitative PCR or immunohistochemistry approaches in detecting LYVE-1 expression in human colorectal tumour. Real-time quantitative polymerase chain reaction (RTQ-PCR) was carried out to quantify LYVE-1 levels in colorectal cancer samples. Also, the same specimen was observed for LYVE-1 expression by immunohistochemical stain. By RTQ-PCR amplification, LYVE-1 was highly expressed in colorectal specimens and LYVE-1 signal from non-cancer tissue of normal control was much weaker by conventional RTPCR. Immunohistochemical stain showed that LYVE-1 was significantly expressed in cancer tissues (especially in the margin region of cancer), whereas in non-cancer specimens fewer positive stains were revealed. The results suggested that the LYVE-I molecule was expressed significantly in colorectal specimens, which may imply a new marker for a malignant situation.

引用

页码：65 / 71

页数：7

共 20 条

[1]

Al-Rawi MAA, 2005, HISTOL HISTOPATHOL, V20, P283, DOI 10.14670/HH-20.283

[2] LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan [J].

Banerji, S ;

Ni, J ;

Wang, SX ;

Clasper, S ;

Su, J ;

Tammi, R ;

Jones, M ;

Jackson, DG .

JOURNAL OF CELL BIOLOGY, 1999, 144 (04) :789-801

[3]

Beasley NJP, 2002, CANCER RES, V62, P1315

[4] High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer [J].

Bono, P ;

Wasenius, VM ;

Heikkilä, P ;

Lundin, J ;

Jackson, DG ;

Joensuu, H .

CLINICAL CANCER RESEARCH, 2004, 10 (21) :7144-7149

[5]

CARR I, 1983, CAN MED ASSOC J, V128, P1164

[6]

Carreira CM, 2001, CANCER RES, V61, P8079

[7] Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model [J].

Cunnick, GH ;

Jiang, WG ;

Gomez, KF ;

Mansel, RE .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 288 (04) :1043-1046

[8] Cancer: Targeting lymphatic metastasis [J].

Gershenwald, JE ;

Fidler, IJ .

SCIENCE, 2002, 296 (5574) :1811-1812

[9] LYVE-1, the lymphatic system and tumor lymphangiogenesis [J].

Jackson, DG ;

Prevo, R ;

Clasper, S ;

Banerji, S .

TRENDS IN IMMUNOLOGY, 2001, 22 (06) :317-321

[10] The lymphatics revisited - New perspectives from the hyaluronan receptor LYVE-1 [J].

Jackson, DG .

TRENDS IN CARDIOVASCULAR MEDICINE, 2003, 13 (01) :1-7

← 1 2 →